Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized comparison of Trizivir versus Kaletra monotherapy for prevention of lipoatrophy in virologically suppressed HIV-1 patients
2008-003438-12Phase 4Active
- Sponsor
- Fundación SEIMC-GeSIDA
- Start
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in Human immunodeficiency virus infection type 1 comparing Trizivir continuation with Kaletra monotherapy (2 arms). Primary endpoint: Mean change in peripheral fat. Started Jul 2008; status: active.
02
Drugs
abacavirlopinavir + ritonavir
03
Conditions
Human immunodeficiency virus infection type 1
Beyond the preview
Go deeper on 2008-003438-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003438-12.